Determinants of Virological Failure in HIV Patients on Highly Active Antiretroviral Therapy (HAART): A Retrospective Cross-Sectional Study in the Upper East Region of Ghana

A. Abubakari, Habibu Issah, M. Awell, Olives Mutaka, M. Asumah
{"title":"Determinants of Virological Failure in HIV Patients on Highly Active Antiretroviral Therapy (HAART): A Retrospective Cross-Sectional Study in the Upper East Region of Ghana","authors":"A. Abubakari, Habibu Issah, M. Awell, Olives Mutaka, M. Asumah","doi":"10.3390/venereology2010002","DOIUrl":null,"url":null,"abstract":"Background: Even though highly active antiretroviral therapy (HAART) for HIV (Human Immune Deficiency) patients has considerably improved viral load suppression, more people still struggle to reduce viral loads. The aim of the study was to determine the associated factors of virological failure in HIV patients on antiretroviral therapy (ART) in the Upper East Region of Ghana. Methods: A retrospective cross-sectional study involving 366 participants aged 15 years and above who were on HAART for six (6) months or longer with viral load results in 2020. Bivariate and multiple logistic regression analyses were conducted to identify the determinants of virological failure among HIV patients at 95% confidence interval (C.I.) with a significant level pegged at a p value less than 0.05. Results: The prevalence of viral load failure was 47.0% and adherence to antiretroviral therapy was 62.6% among patients on HAART. The significant predicators of virological failure were basic education (AOR (adjusted odds ratio) = 7.36, 95% C.I = 4.91–59.71), High school/Vocational /Technical education (AOR = 4.70, 95% C.I. = 1.90–9.69), monthly salary/income ˂ GHS 375.00 (AOR = 7.20, 95% C.I. = 1.73–29.95), duration on ART for ˂1 year (AOR = 0.27, 95% C.I. = 0.10–0.75), ART regimen (Tenofovir + Lamivudine + Efavirenz) (AOR = 3.26, 95% C.I. = 1.95–11.25), 3–5 times missed medication per month (AOR = 2.86, 95% C.I. = 1.34–6.08) and ≥6 missed medication per month (AOR = 23.87, 95% C.I. = 10.57–53.92). Conclusion: Educational status, salary/income, ART duration, ART combination regimen, and number of doses missed were statistically significantly associated with virological failure in patients on antiretroviral therapy. The majority of the respondents adhered to ART, which led to moderate viral load suppression but lower than the target for 2020. There is the need to strengthen the ongoing accelerated social behavior change communication among patients on ART to enhance adherence in order to attain the new UNAIDS target of 95% viral load suppression by 2030 in the Upper East Region of Ghana.","PeriodicalId":75296,"journal":{"name":"Venereology (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Venereology (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/venereology2010002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Even though highly active antiretroviral therapy (HAART) for HIV (Human Immune Deficiency) patients has considerably improved viral load suppression, more people still struggle to reduce viral loads. The aim of the study was to determine the associated factors of virological failure in HIV patients on antiretroviral therapy (ART) in the Upper East Region of Ghana. Methods: A retrospective cross-sectional study involving 366 participants aged 15 years and above who were on HAART for six (6) months or longer with viral load results in 2020. Bivariate and multiple logistic regression analyses were conducted to identify the determinants of virological failure among HIV patients at 95% confidence interval (C.I.) with a significant level pegged at a p value less than 0.05. Results: The prevalence of viral load failure was 47.0% and adherence to antiretroviral therapy was 62.6% among patients on HAART. The significant predicators of virological failure were basic education (AOR (adjusted odds ratio) = 7.36, 95% C.I = 4.91–59.71), High school/Vocational /Technical education (AOR = 4.70, 95% C.I. = 1.90–9.69), monthly salary/income ˂ GHS 375.00 (AOR = 7.20, 95% C.I. = 1.73–29.95), duration on ART for ˂1 year (AOR = 0.27, 95% C.I. = 0.10–0.75), ART regimen (Tenofovir + Lamivudine + Efavirenz) (AOR = 3.26, 95% C.I. = 1.95–11.25), 3–5 times missed medication per month (AOR = 2.86, 95% C.I. = 1.34–6.08) and ≥6 missed medication per month (AOR = 23.87, 95% C.I. = 10.57–53.92). Conclusion: Educational status, salary/income, ART duration, ART combination regimen, and number of doses missed were statistically significantly associated with virological failure in patients on antiretroviral therapy. The majority of the respondents adhered to ART, which led to moderate viral load suppression but lower than the target for 2020. There is the need to strengthen the ongoing accelerated social behavior change communication among patients on ART to enhance adherence in order to attain the new UNAIDS target of 95% viral load suppression by 2030 in the Upper East Region of Ghana.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高活性抗逆转录病毒疗法(HAART)HIV患者病毒学失败的决定因素:加纳上东部地区的回顾性横断面研究
背景:尽管针对HIV(人类免疫缺陷)患者的高活性抗逆转录病毒疗法(HAART)显著改善了病毒载量的抑制,但仍有更多的人在努力降低病毒载量。该研究的目的是确定加纳上东部地区接受抗逆转录病毒疗法(ART)的HIV患者病毒学失败的相关因素。方法:一项回顾性横断面研究涉及366名年龄在15岁及以上的参与者,他们在2020年接受HAART治疗六(6)个月或更长时间,并获得病毒载量结果。进行双变量和多元逻辑回归分析,以95%置信区间(C.I.)确定HIV患者病毒学失败的决定因素,显著水平与p值小于0.05挂钩。结果:在接受HAART的患者中,病毒载量失败的发生率为47.0%,坚持抗逆转录病毒疗法的发生率是62.6%。病毒学失败的重要预测因素是基础教育(AOR(调整后的比值比)=7.36,95%C.I=4.91–59.71)、高中/职业/技术教育(AOR=4.70,95%C.I.=1.90–9.69)、月薪/收入375.00 GHS(AOR=7.20,95%C.=1.73–29.95)、抗逆转录病毒疗法持续时间1年(AOR=0.27,95%C.I.=0.10–0.75),ART方案(替诺福韦+拉米夫定+埃法韦仑)(AOR=3.26,95%CI=1.95-11.25),每月漏药3-5次(AOR=2.86,95%CI=1.34-6.08)和每月漏药≥6次(AOR=23.87,95%CI=10.57-53.92),和漏服剂量数在统计学上与抗逆转录病毒治疗患者的病毒学失败显著相关。大多数受访者坚持抗逆转录病毒疗法,这导致了适度的病毒载量抑制,但低于2020年的目标。有必要加强抗逆转录病毒疗法患者之间正在进行的加速社会行为改变沟通,以提高依从性,从而实现联合国艾滋病规划署到2030年在加纳上东部地区抑制95%病毒载量的新目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Screening for HPV-Related Oropharyngeal Cancer in Gay and Bisexual Men: Acceptability and Predicting Possible Use of "Oral Selfies" by Smartphone as a Secondary Prevention Approach. Racial Disparities Associated with Increased Burden of Sexually Transmitted Infections in North Carolina, Southeastern United States Seroprevalence of Human Cytomegalovirus Infection among HIV Patients in Edo State, Southern Nigeria Advancing Syphilis Research: Exploring New Frontiers in Immunology and Pharmacological Interventions Pangenome Analysis Reveals a High Degree of Genetic Diversity in Gardnerella vaginalis: An In Silico Approach
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1